Bizarre Patents
Wearable Device For Feeding and Observing Birds and Other Flying Animals
A device for feeding and observing flying animals comprising a hat, a support mounted on the hat and extending outward from the hat, and a feeder mounted on the support.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6656928 | Composition for the topical treatment of rashes, dermatoses and lesions Composition for topical administration comprising (a) a corticosteroid, (b) a drying agent, and (c) a broad spectrum anti-fungal agent that treats both dermatophytes and yeast.... | 12/02/2003 |
| 6653335 | Pharmaceutical composition for inhibiting the growth of viruses and cancers This invention is a method of treating cancer, both carcinomas and sarcomas, and viral infections, in particular HIV through the administration of a pharmaceutical composition containing a benzimidazole derivative. The composition is also claimed. The ben... | 11/25/2003 |
| 6635630 | Selective neurokinin antagonists Compound represented by the structural formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein Ar1 and Ar2 are optionally substituted heteroaryl or optionally substituted phenyl; X1 is --O--, --S--, --SO--, ... | 10/21/2003 |
| 6613789 | Heterocyclo-substituted imidazoles for the treatment of inflammation A class of imidazolyl compounds is described for use in treating inflammation. Compounds of particular interest are defined by Formula V: ##STR1## and pharmaceutically-acceptable salts thereof.... | 09/02/2003 |
| 6613788 | Elevation of circulating blood histamine levels Methods for obtaining beneficial stable levels of circulating histamine are disclosed for use in methods for enhancing natural killer cell cytotoxicity and for elevating histamine levels in individuals in need thereof. In such methods, a beneficial level ... | 09/02/2003 |
| 6610746 | Synergistic effect of a sulfonylurea and/or non-sulfonylurea K+ATP channel blocker, and a phosphodiesterase 3 type inhibitor The present invention provides methods of treating non-insulin dependent diabetes mellitus, insulin resistance, Syndrome X, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, polycystic ovary syndrome, cataracts, hyp... | 08/26/2003 |
| 6610682 | Pharmaceutical compositions and methods for the treatment of arteriosclerosis A pharmaceutical composition comprising as its active ingredients one or more drugs selected from the group consisting of angiotensin II receptor antagonists and angiotensin converting enzyme inhibitors, and one or more insulin resistance improving agents... | 08/26/2003 |
| 6602896 | p38MAPK inhibitor and uses thereof The present invention demonstrates that p38MAPK inhibitor induces low density lipoprotein receptor expression 6-8 fold, and further provides the application of such inhibitor in the treatment of hypercholesterolemia.... | 08/05/2003 |
| 6599926 | Heteroaryl-phenyl substituted factor Xa inhibitors The present application describes heteroaryl-phenyl substituted compounds and derivatives thereof, or pharmaceutically acceptable salt or prodrug forms thereof, which are useful as inhibitors of factor Xa.... | 07/29/2003 |
| 6582683 | Dermal barrier composition Disclosed is a dermal barrier composition which contains a hydrophilic polymer emulsion and a hydrophobic polymer emulsion. The dermal barrier composition is moisture activated, and remains inert until the hydrophobic and hydrophilic polymer emulsions con... | 06/24/2003 |
| 6582457 | Method of controlling body temperature while reducing shivering A method and apparatus for lowering the body temperature of a patient while reducing shivering by using a heat exchange device in combination with an 댒-adrenoreceptor agonist, a non-opiod analgesic monoamine uptake inhibitor or neuropeptide that te... | 06/24/2003 |
| 6576652 | Use of an angiotensin II receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients The present invention relates to the use, for the preparation of drugs to increase the survival rate of transplant patients, including renal and heart transplant patients, of a therapeutically effective amount of an angiotension II receptor antagonist com... | 06/10/2003 |
| 6576645 | Triphenylalkene derivatives and their use as selective estrogen receptor modulators The invention provides novel selective estrogen receptor modulator compounds of the general formula: ##STR1## wherein R1 and R2, which are the same or different are a) H, halogen, OCH3, OH; or ##STR2## where X is O, NH or S; and n is an intege... | 06/10/2003 |
| 6565894 | Healthcare formulations comprising imidazole and hydrogen peroxide An ophthalmic solution comprising: 0.01 to 5 weight percent imidazole: 0.01 to 30 weight percent hydrogen peroxide and the balance water which can further comprisie 0.01 to 2 weight percent of a buffer adjusted so the pH of the formulation is between 5.5 ... | 05/20/2003 |
| 6566381 | Hetero-substituted metalloprotease inhibitors Heterocyclic substituted compounds having the general structure: ##STR1## which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes.... | 05/20/2003 |
| 6559172 | Disubstituted imidazoles useful in the treatment of bacterial infections Novel disubstituted imidazoles are disclosed which are useful in the treatment of bacterial infections, particularly through the inhibition of FAB I.... | 05/06/2003 |
| 6559157 | Dihydronaphthalene compounds Dihydronaphthalene compounds have excellent 17-hydroxylase/C17-20 -lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or thera... | 05/06/2003 |
| 6551583 | Antibiofouling method and apparatus for optical sensors An antibiofouling material, a method for making said antibiofouling material, a sensor apparatus employing said antibiofouling material, and a method of making said sensor apparatus. The disclosed antibiofouling material includes one or more biocides and ... | 04/22/2003 |
| 6552060 | Asymmetric disulfides and methods of using same The present invention is directed to a composition or formulation which includes an asymmetric disulfide which alone or in combination inhibits or interferes with cellular redox function, as well as a method of using same to restore normal cellular functi... | 04/22/2003 |
| 6545028 | Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction This invention relates to treatment or alleviation of a disease, condition or disorder selected from inflammatory bowel disease, Chron's disease, colitis ulcerosa, Coeliac disease, dermatitis herpetiformis, dermatomyositis, enteritis allergia, erytherma n... | 04/08/2003 |
| 6545009 | Retinoid-related receptor function regulating agent 1,3-Azole derivatives, pharmaceutical compositions thereof and methods for regulating the function of retinoid-related receptors with 1,3-azole derivatives are disclosed. Such regulation may be useful for preventing or treating diabetes, preventing or tre... | 04/08/2003 |
| 6544550 | Medicaments for gastrointestinal disorders The invention relates to the co-administration in human or veterinary medicine of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carba zol-4-one or a physiologically acceptable salt or solvate thereof and dexamethasone or a physi... | 04/08/2003 |
| 6541505 | Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds This invention is directed to an (aminoiminomethyl or aminomethyl)benzoheteroaryl compound of formula I which is useful for inhibiting the activity of Factor Xa by combining said compound with a composition containing Factor Xa. The present invention is a... | 04/01/2003 |
| 6541421 | Buffered phosphorus containing solution This invention relates to a buffered phosphorus containing solution comprising at least one phosphorus compound selected from the group consisting of phosphorous acid, hypophosphorous acid, polyphosphorous acid polyhypophosphorous acid, and salts thereof.... | 04/01/2003 |
| 6537970 | Pharmaceutical composition The invention relates to a novel pharmaceutical combination comprising clindamycin and clotrimazole for use for vaginal infections.... | 03/25/2003 |
| 6525082 | Apoptosis inducer A substance for inducing apoptosis represented by specific formulae. A pharmaceutical composition which can be used for an anticancer agent containing said substance.... | 02/25/2003 |
| 6518287 | Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists The present invention discloses novel substituted imidazole compounds which have either or dual histamine-H1 and H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention di... | 02/11/2003 |
| 6515007 | Methods for managing scalp conditions This application relates to a pharmaceutical composition for the prevention, treatment, and management of scalp conditions, such as dandruff, seborrheic dermatitis, psoriasis, folliculitis, and hair thinning including a therapeutically effective amount of... | 02/04/2003 |
| 6514966 | Compounds for the treatment of obesity NPY antagonists, methods of using such NPY antagonists and pharmaceutical compositions containing such NPY antagonists. The NPY antagonists are useful for the treatment of NPY mediated disease/conditions including obesity.... | 02/04/2003 |
| 6514934 | Imidazoline -adrenergic receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use The present invention is directed to nitrosated or nitrosylated -adrenergic receptor antagonists, compositions comprising -adrenergic receptor antagonists that are optionally substituted with at least one NO or NO2 moiety and comp... | 02/04/2003 |
| 6512000 | Aminocarbonyl-substituted benzimidazoles having tryptase-inhibitory activity A method for treating diseases in which tryptase inhibitors may be of thereapeutic value, which comprises the administration of a thereapeutic amount of a compound of the formula ##STR1## The invention also comprises novel compounds of the formula (I). Exempla... | 01/28/2003 |
| 6500855 | Thrombin or factor Xa inhibitors This invention relates generally to inhibitors of trypsin-like serine protease enzymes, especially factor Xa or thrombin, pharmaceutical compositions containing the same, and methods of using the same as anticoagulant agents for treatment and prevention o... | 12/31/2002 |
| 6498181 | Synergistic tumorcidal response induced by histamine The present invention relates to methods of treating cancer in which histamine is administered in conjunction with other cancer therapies. The cancer therapy includes surgery, radiation, immunotherapy, the administration of an agent which enhances the hum... | 12/24/2002 |
| 6489365 | Amidine derivatives, the preparation and use thereof as medicaments with Itb4 antagonistic effect Compounds of the formula ##STR1## which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.... | 12/03/2002 |
| 6479530 | Imidazole derivatives having affinity for 댒 receptors Imidazole derivatives of formula I ##STR1## wherein n is 0 or 1, R1 is hydrogen or C1 -C4 -alkyl, R2 is hydrogen or R2 and R3 together form a double bond, R3 is hydrogen or C | 11/12/2002 |
| 6479526 | Pharmaceutical composition for inhibiting the growth of viruses and cancers This invention is a method of treating cancer, both carcinomas and sarcomas, and viral infections, in particular HIV through the administration of a pharmaceutical composition containing a benzimidazole derivative. The composition is also claimed. The ben... | 11/12/2002 |
| 6462065 | Use of 5-HT3 receptor antagonists for treating musculoeskeletal diseases The present invention relates to a new use for compounds having 5-HT3 (serotonin M) receptor antagonist activity, especially tropisetron, for the manufacture of a pharmaceutical composition for the treatment of a non-inflammatory local disease ... | 10/08/2002 |
| 6455565 | Method for inhibiting skin lesion formation using histamine as the active ingredient A pharmaceutical composition of water, water soluble vinyl polymer gel, amine alcohol dispersant and IEP is used topically to treat herpes labialis and aphthous stomatitis lesions, and also to treat herpes genitalis, chicken pox, allergic conjunctivitis, ... | 09/24/2002 |
| 6451830 | Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for t... | 09/17/2002 |
| 6436928 | Selective neurokinin antagonists A compound represented by the structural formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein Ar1 and Ar2 are optionally substituted heteroaryl or optionally substituted phenyl; X1 is --O--, --SO0-2 | 08/20/2002 |
